Cargando…
Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and highly lethal lung disease with unknown etiology and poor prognosis. IPF patients die within 2 years after diagnosis mostly due to respiratory failure. Current treatments against IPF aim to ameliorate patient symptoms and to delay di...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527704/ https://www.ncbi.nlm.nih.gov/pubmed/31110176 http://dx.doi.org/10.1038/s41467-019-10066-7 |
_version_ | 1783420068647927808 |
---|---|
author | Rubio, Karla Singh, Indrabahadur Dobersch, Stephanie Sarvari, Pouya Günther, Stefan Cordero, Julio Mehta, Aditi Wujak, Lukasz Cabrera-Fuentes, Hector Chao, Cho-Ming Braubach, Peter Bellusci, Saverio Seeger, Werner Günther, Andreas Preissner, Klaus T. Wygrecka, Malgorzata Savai, Rajkumar Papy-Garcia, Dulce Dobreva, Gergana Heikenwalder, Mathias Savai-Pullamsetti, Soni Braun, Thomas Barreto, Guillermo |
author_facet | Rubio, Karla Singh, Indrabahadur Dobersch, Stephanie Sarvari, Pouya Günther, Stefan Cordero, Julio Mehta, Aditi Wujak, Lukasz Cabrera-Fuentes, Hector Chao, Cho-Ming Braubach, Peter Bellusci, Saverio Seeger, Werner Günther, Andreas Preissner, Klaus T. Wygrecka, Malgorzata Savai, Rajkumar Papy-Garcia, Dulce Dobreva, Gergana Heikenwalder, Mathias Savai-Pullamsetti, Soni Braun, Thomas Barreto, Guillermo |
author_sort | Rubio, Karla |
collection | PubMed |
description | Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and highly lethal lung disease with unknown etiology and poor prognosis. IPF patients die within 2 years after diagnosis mostly due to respiratory failure. Current treatments against IPF aim to ameliorate patient symptoms and to delay disease progression. Unfortunately, therapies targeting the causes of or reverting IPF have not yet been developed. Here we show that reduced levels of miRNA lethal 7d (MIRLET7D) in IPF compromise epigenetic gene silencing mediated by the ribonucleoprotein complex MiCEE. In addition, we find that hyperactive EP300 reduces nuclear HDAC activity and interferes with MiCEE function in IPF. Remarkably, EP300 inhibition reduces fibrotic hallmarks of in vitro (patient-derived primary fibroblast), in vivo (bleomycin mouse model), and ex vivo (precision-cut lung slices, PCLS) IPF models. Our work provides the molecular basis for therapies against IPF using EP300 inhibition. |
format | Online Article Text |
id | pubmed-6527704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-65277042019-05-22 Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis Rubio, Karla Singh, Indrabahadur Dobersch, Stephanie Sarvari, Pouya Günther, Stefan Cordero, Julio Mehta, Aditi Wujak, Lukasz Cabrera-Fuentes, Hector Chao, Cho-Ming Braubach, Peter Bellusci, Saverio Seeger, Werner Günther, Andreas Preissner, Klaus T. Wygrecka, Malgorzata Savai, Rajkumar Papy-Garcia, Dulce Dobreva, Gergana Heikenwalder, Mathias Savai-Pullamsetti, Soni Braun, Thomas Barreto, Guillermo Nat Commun Article Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and highly lethal lung disease with unknown etiology and poor prognosis. IPF patients die within 2 years after diagnosis mostly due to respiratory failure. Current treatments against IPF aim to ameliorate patient symptoms and to delay disease progression. Unfortunately, therapies targeting the causes of or reverting IPF have not yet been developed. Here we show that reduced levels of miRNA lethal 7d (MIRLET7D) in IPF compromise epigenetic gene silencing mediated by the ribonucleoprotein complex MiCEE. In addition, we find that hyperactive EP300 reduces nuclear HDAC activity and interferes with MiCEE function in IPF. Remarkably, EP300 inhibition reduces fibrotic hallmarks of in vitro (patient-derived primary fibroblast), in vivo (bleomycin mouse model), and ex vivo (precision-cut lung slices, PCLS) IPF models. Our work provides the molecular basis for therapies against IPF using EP300 inhibition. Nature Publishing Group UK 2019-05-20 /pmc/articles/PMC6527704/ /pubmed/31110176 http://dx.doi.org/10.1038/s41467-019-10066-7 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Rubio, Karla Singh, Indrabahadur Dobersch, Stephanie Sarvari, Pouya Günther, Stefan Cordero, Julio Mehta, Aditi Wujak, Lukasz Cabrera-Fuentes, Hector Chao, Cho-Ming Braubach, Peter Bellusci, Saverio Seeger, Werner Günther, Andreas Preissner, Klaus T. Wygrecka, Malgorzata Savai, Rajkumar Papy-Garcia, Dulce Dobreva, Gergana Heikenwalder, Mathias Savai-Pullamsetti, Soni Braun, Thomas Barreto, Guillermo Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis |
title | Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis |
title_full | Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis |
title_fullStr | Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis |
title_full_unstemmed | Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis |
title_short | Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis |
title_sort | inactivation of nuclear histone deacetylases by ep300 disrupts the micee complex in idiopathic pulmonary fibrosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527704/ https://www.ncbi.nlm.nih.gov/pubmed/31110176 http://dx.doi.org/10.1038/s41467-019-10066-7 |
work_keys_str_mv | AT rubiokarla inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT singhindrabahadur inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT doberschstephanie inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT sarvaripouya inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT guntherstefan inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT corderojulio inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT mehtaaditi inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT wujaklukasz inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT cabrerafuenteshector inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT chaochoming inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT braubachpeter inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT belluscisaverio inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT seegerwerner inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT guntherandreas inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT preissnerklaust inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT wygreckamalgorzata inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT savairajkumar inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT papygarciadulce inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT dobrevagergana inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT heikenwaldermathias inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT savaipullamsettisoni inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT braunthomas inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis AT barretoguillermo inactivationofnuclearhistonedeacetylasesbyep300disruptsthemiceecomplexinidiopathicpulmonaryfibrosis |